Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 406 participants.
Also called NCT03540355
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 406 participants
- Sponsor
- EMS
- Registry
-
NCT03540355
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Brazil
- Registry status
- Completed
Technical summary
Registry record NCT03540355. Randomized; double masking; primary purpose treatment. Start 2021-03-02 (actual); primary completion 2025-01-23 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment
- Acronym
- CIPROS20
- Condition
- Dyslipidemias
- Intervention (Drug)
- Cipros 20 association
- Intervention (Drug)
- Crestor 20 mg
- Lead sponsor
- EMS
Record details
- Record id
cardio:ct-nct03540355- Content hash
d973f9ce5ddaa1d8f159a3f3b46a0b207f65b5b458654917568ee65e9086abab